Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,898 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis buffer.
Erster O, Shkedi O, Benedek G, Zilber E, Varkovitzky I, Shirazi R, Shorka DO, Cohen Y, Bar T, Yechieli R, Oikawa MT, Venkert D, Linial M, Oiknine-Djian E, Mandelboim M, Livneh Z, Shenhav-Saltzman G, Mendelson E, Wolf D, Szwarcwort-Cohen M, Mor O, Lewis Y, Zeevi D. Erster O, et al. Among authors: wolf d. PLoS One. 2024 Nov 14;19(11):e0314219. doi: 10.1371/journal.pone.0314219. eCollection 2024. PLoS One. 2024. PMID: 39541366 Free PMC article.
Clinical impact of circulating biomarkers in prediction of adverse cardiac events in patients with congenital heart disease. A systematic review.
van Genuchten WJ, Averesch H, van Dieren QM, Bonnet D, Odemarsky M, Beghetti M, Roos-Hesselink JW, Reinhardt Z, Male C, Naumburg E, Boersma E, De Wolf D, Helbing WA; also on behalf of Cardiology Expert Group of the connect4children (c4c) network. van Genuchten WJ, et al. Among authors: de wolf d. Int J Cardiol. 2024 Nov 10:132723. doi: 10.1016/j.ijcard.2024.132723. Online ahead of print. Int J Cardiol. 2024. PMID: 39532255
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer.
Campbell MJ, Wolf DM, Yau C, Brown-Swigart L, Wulfkuhle J, Gallagher IR, Zhu Z, Bolen J, Vandenberg S, Hoyt C, Mori H, Borowsky A, Sit L, Perlmutter J, Asare SM; I-SPY2 Investigators; Nanda R, Liu MC, Yee D, DeMichele AM, Hylton NM, Pusztai L, Berry DA, Hirst GL, Petricoin EF, Veer LV, Esserman L. Campbell MJ, et al. Among authors: wolf dm. Cell Rep Med. 2024 Nov 3:101799. doi: 10.1016/j.xcrm.2024.101799. Online ahead of print. Cell Rep Med. 2024. PMID: 39510069 Free article.
Lymphatic Disorder Management in Pediatric Patients With Congenital Heart Disease in European Pediatric Cardiology Centers: Current Status, Disparities, and Future Considerations.
Safi S, Hjortdal VE, Gewillig M, Miller O, Abumehdi MR, Cantinotti M, Grotenhuis H, Raimondi F, Garrido AO, Roest A, Sunnegårdh J, Saleats T, Brun H, Pärna H, Nolan O, Rotés AS, Deri A, De Wolf D, Herberg U, Liuba P, Möller T, Óskarsson G, Rebonato M, Helbing WA, Doros G, Muntean I, Ojala T, Lubaua I, Bhat M, Wacker J, Bonello B, Ramcharan T, Greil G, Sendzikaite S, Bonnet D, Marek J, Voges I, McMahon CJ. Safi S, et al. Among authors: de wolf d. J Am Heart Assoc. 2024 Nov 7:e036597. doi: 10.1161/JAHA.124.036597. Online ahead of print. J Am Heart Assoc. 2024. PMID: 39508150 Free article.
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial.
Huppert LA, Wolf D, Yau C, Brown-Swigart L, Hirst GL, Isaacs C, Pusztai L, Pohlmann PR, DeMichele A, Shatsky R, Yee D, Thomas A, Nanda R, Perlmutter J, Heditsian D, Hylton N, Symmans F, Veer LJV', Esserman L, Rugo HS. Huppert LA, et al. Among authors: wolf d. Ann Oncol. 2024 Oct 28:S0923-7534(24)04070-5. doi: 10.1016/j.annonc.2024.10.018. Online ahead of print. Ann Oncol. 2024. PMID: 39477071
Impact of neonatal hyperoxia on adult cardiac autonomic function in rats: Role of angiotensin II type 1 receptor activation.
Poletto Bonetto JH, Deprez A, Wolf D, Oliveira Fernandes R, Casali K, Sonea A, Flahault A, Siqueira Flores M, He Y, Belló-Klein A, Ravizzoni Dartora D, Nuyt AM. Poletto Bonetto JH, et al. Among authors: wolf d. Eur J Pharmacol. 2024 Dec 5;984:177026. doi: 10.1016/j.ejphar.2024.177026. Epub 2024 Oct 11. Eur J Pharmacol. 2024. PMID: 39396751
Reproducible Sex Differences in Personalized Functional Network Topography in Youth.
Keller AS, Sun KY, Francisco A, Robinson H, Beydler E, Bassett DS, Cieslak M, Cui Z, Davatzikos C, Fan Y, Gardner M, Kishton R, Kornfield SL, Larsen B, Li H, Linder I, Pines A, Pritschet L, Raznahan A, Roalf DR, Seidlitz J, Shafiei G, Shinohara RT, Wolf DH, Alexander-Bloch A, Satterthwaite TD, Shanmugan S. Keller AS, et al. Among authors: wolf dh. bioRxiv [Preprint]. 2024 Sep 29:2024.09.26.615061. doi: 10.1101/2024.09.26.615061. bioRxiv. 2024. PMID: 39386637 Free PMC article. Preprint.
A Belgian consensus on sotatercept for the treatment of pulmonary arterial hypertension.
Vachiéry JL, Belge C, Cools B, Damen A, Demeure F, De Pauw M, Dewachter C, De Wolf D, Gabriel L, Godinas L, Guiot J, Haine S, Leys M, Meysman M, Pouleur AC, Ruttens D, Vandecasteele E, Vansteenkiste W, Weber T, Wirtz G, Delcroix M. Vachiéry JL, et al. Among authors: de wolf d. Acta Cardiol. 2024 Oct 8:1-6. doi: 10.1080/00015385.2024.2408130. Online ahead of print. Acta Cardiol. 2024. PMID: 39377139 Review.
2,898 results